194 filings
Page 6 of 10
8-K
i30y8ha p9313xpco
15 Mar 18
Neos Therapeutics Reports Fourth Quarter and Full-Year 2017 Financial Results
12:00am
8-K
xmv81wi3x sq45bs
8 Nov 17
Neos Therapeutics Reports Third Quarter 2017 Financial Results
12:00am
8-K
4lw otkdy0em2k1ts
1 Nov 17
Other Events
12:00am
8-K
x0pazi
18 Oct 17
Entry into a Material Definitive Agreement
12:00am
8-K
p610b
2 Oct 17
Other Events
12:00am
8-K
4rr9rrj5le2xqfp0k99m
15 Sep 17
Neos Therapeutics Receives U.S. FDA Approval of
12:00am
8-K
gq1swzy7 tf3il
8 Aug 17
Neos Therapeutics Reports Second Quarter 2017 Financial Results
12:00am
EFFECT
bvynuw3u
11 Jul 17
Notice of effectiveness
12:00am
424B3
l76a3 v67kuus5s3d
11 Jul 17
Prospectus supplement
12:00am
CORRESP
7h1xoxtj2hm2m
7 Jul 17
Correspondence with SEC
12:00am
UPLOAD
uu35760sfmyfk6ih8am
7 Jul 17
Letter from SEC
12:00am
8-K
n1sfd 7pbvikvfm
29 Jun 17
Neos Therapeutics Announces Pricing of Underwritten Public Offering of $32.4 Million of Common Stock
12:00am
CT ORDER
cveizh jq
28 Jun 17
Confidential treatment order
12:00am
424B5
qd7rk l57193
28 Jun 17
Prospectus supplement for primary offering
12:00am
8-K
g4441j h1zwfe
26 Jun 17
Neos Therapeutics Announces Proposed Offering of Common Stock
12:00am
424B5
etslgg27mngm4c 29
26 Jun 17
Prospectus supplement for primary offering
12:00am
8-K
ikrgq r7ilw
20 Jun 17
Neos Therapeutics Announces FDA Approval of
12:00am